Media Centre
Latest press releases
-
Lynparza receives additional and broad approval in the US for ovarian cancer
-
US FDA accepts regulatory submission for acalabrutinib and grants Priority Review
-
Acalabrutinib granted Breakthrough Therapy Designation by US FDA for the treatment of patients with mantle cell lymphoma
-
Imfinzi granted Breakthrough Therapy Designation by US FDA for patients with locally-advanced unresectable non-small cell lung cancer
-
Tagrisso significantly improves progression-free survival in the Phase III FLAURA trial for lung cancer
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Esra Erkal-Paler
Global Head of External Communications
Karen Birmingham
Director Global Science Media
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Jacob Lund
Director External Communications, Sweden
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
